Banks - Regional
Compare Stocks
4 / 10Stock Comparison
BRBS vs NKSH vs NBTB vs CARE
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
BRBS vs NKSH vs NBTB vs CARE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $320M | $240M | $2.35B | $580M |
| Revenue (TTM) | $151M | $85M | $867M | $255M |
| Net Income (TTM) | $11M | $16M | $169M | $31M |
| Gross Margin | 63.5% | 65.1% | 72.1% | 61.7% |
| Operating Margin | 9.1% | 22.5% | 25.3% | 15.7% |
| Forward P/E | 31.8x | 11.7x | 10.8x | 4.8x |
| Total Debt | $179M | $2M | $327M | $179M |
| Cash & Equiv. | $116M | $8M | $185M | $105M |
BRBS vs NKSH vs NBTB vs CARE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Blue Ridge Bankshar… (BRBS) | 100 | 36.0 | -64.0% |
| National Bankshares… (NKSH) | 100 | 122.4 | +22.4% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRBS vs NKSH vs NBTB vs CARE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRBS has the current edge in this matchup, primarily because of its strength in income & stability and bank quality.
- Dividend streak 0 yrs, beta 0.54, yield 6.1%
- NIM 3.2% vs NKSH's 2.5%
- Beta 0.54 vs NBTB's 0.89
- 6.1% yield, vs NBTB's 3.2%, (1 stock pays no dividend)
NKSH is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 7.9%, EPS growth 100.8%
- Lower volatility, beta 0.76, Low D/E 1.1%, current ratio 1203.84x
- Beta 0.76, yield 4.0%, current ratio 1203.84x
- Efficiency ratio 0.4% vs BRBS's 0.5% (lower = leaner)
NBTB is the clearest fit if your priority is growth and value.
- 10.4% NII/revenue growth vs BRBS's -13.4%
- Lower P/E (10.8x vs 11.7x), PEG 1.53 vs 145.48
CARE is the clearest fit if your priority is long-term compounding.
- 112.9% 10Y total return vs NBTB's 102.2%
- +69.0% vs NBTB's +9.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% NII/revenue growth vs BRBS's -13.4% | |
| Value | Lower P/E (10.8x vs 11.7x), PEG 1.53 vs 145.48 | |
| Quality / Margins | Efficiency ratio 0.4% vs BRBS's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.54 vs NBTB's 0.89 | |
| Dividends | 6.1% yield, vs NBTB's 3.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +69.0% vs NBTB's +9.0% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs BRBS's 0.5% |
BRBS vs NKSH vs NBTB vs CARE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRBS vs NKSH vs NBTB vs CARE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 2 of 6 categories
NKSH leads 1 • CARE leads 1 • BRBS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 10.2x NKSH's $85M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to BRBS's 7.1%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $151M | $85M | $867M | $255M |
| EBITDAEarnings before interest/tax | $15M | $20M | $241M | $46M |
| Net IncomeAfter-tax profit | $11M | $16M | $169M | $31M |
| Free Cash FlowCash after capex | $9M | $17M | $225M | $30M |
| Gross MarginGross profit ÷ Revenue | +63.5% | +65.1% | +72.1% | +61.7% |
| Operating MarginEBIT ÷ Revenue | +9.1% | +22.5% | +25.3% | +15.7% |
| Net MarginNet income ÷ Revenue | +7.1% | +18.6% | +19.5% | +12.3% |
| FCF MarginFCF ÷ Revenue | +2.5% | +17.8% | +25.2% | +12.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +2.6% | +91.7% | +39.5% | +8.3% |
Valuation Metrics
NBTB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, NBTB trades at a 57% valuation discount to BRBS's 31.8x P/E. Adjusting for growth (PEG ratio), NBTB offers better value at 1.92x vs NKSH's 145.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $320M | $240M | $2.4B | $580M |
| Enterprise ValueMkt cap + debt − cash | $383M | $234M | $2.5B | $654M |
| Trailing P/EPrice ÷ TTM EPS | 31.82x | 15.14x | 13.53x | 18.71x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.71x | 10.80x | 4.77x |
| PEG RatioP/E ÷ EPS growth rate | — | 145.48x | 1.92x | — |
| EV / EBITDAEnterprise value multiple | 25.54x | 12.20x | 10.35x | 16.34x |
| Price / SalesMarket cap ÷ Revenue | 2.13x | 2.81x | 2.71x | 2.28x |
| Price / BookPrice ÷ Book value/share | 1.15x | 1.30x | 1.21x | 1.40x |
| Price / FCFMarket cap ÷ FCF | 85.53x | 15.85x | 10.75x | 18.25x |
Profitability & Efficiency
NKSH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NBTB delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $3 for BRBS. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRBS's 0.55x. On the Piotroski fundamental quality scale (0–9), NKSH scores 8/9 vs BRBS's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.1% | +9.0% | +9.5% | +7.6% |
| ROA (TTM)Return on assets | +0.4% | +0.9% | +1.1% | +0.7% |
| ROICReturn on invested capital | +2.0% | +8.4% | +7.9% | +5.7% |
| ROCEReturn on capital employed | +0.5% | +1.9% | +2.4% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.55x | 0.01x | 0.17x | 0.43x |
| Net DebtTotal debt minus cash | $63M | -$6M | $142M | $73M |
| Cash & Equiv.Liquid assets | $116M | $8M | $185M | $105M |
| Total DebtShort + long-term debt | $179M | $2M | $327M | $179M |
| Interest CoverageEBIT ÷ Interest expense | 0.23x | 0.64x | 1.05x | 0.39x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $3,234 for BRBS. Over the past 12 months, CARE leads with a +69.0% total return vs NBTB's +9.0%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.9% vs BRBS's -17.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.4% | +14.2% | +9.3% | +34.8% |
| 1-Year ReturnPast 12 months | +24.6% | +49.7% | +9.0% | +69.0% |
| 3-Year ReturnCumulative with dividends | -43.9% | +55.1% | +54.1% | +94.7% |
| 5-Year ReturnCumulative with dividends | -67.7% | +31.9% | +29.9% | +87.2% |
| 10-Year ReturnCumulative with dividends | -12.5% | +51.3% | +102.2% | +112.9% |
| CAGR (3Y)Annualised 3-year return | -17.5% | +15.7% | +15.5% | +24.9% |
Risk & Volatility
Evenly matched — BRBS and CARE each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRBS is the less volatile stock with a 0.54 beta — it tends to amplify market swings less than NBTB's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 98.5% from its 52-week high vs BRBS's 73.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.54x | 0.76x | 0.89x | 0.56x |
| 52-Week HighHighest price in past year | $4.79 | $40.00 | $46.92 | $26.58 |
| 52-Week LowLowest price in past year | $3.25 | $24.74 | $39.20 | $15.37 |
| % of 52W HighCurrent price vs 52-week peak | +73.1% | +94.3% | +96.1% | +98.5% |
| RSI (14)Momentum oscillator 0–100 | 35.1 | 51.1 | 57.3 | 75.4 |
| Avg Volume (50D)Average daily shares traded | 380K | 50K | 236K | 276K |
Analyst Outlook
Evenly matched — BRBS and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NKSH as "Buy", NBTB as "Hold", CARE as "Buy". Consensus price targets imply 3.1% upside for CARE (target: $27) vs 2.1% for NBTB (target: $46). For income investors, BRBS offers the higher dividend yield at 6.08% vs NBTB's 3.17%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $46.00 | $27.00 |
| # AnalystsCovering analysts | — | 4 | 10 | 4 |
| Dividend YieldAnnual dividend ÷ price | +6.1% | +4.0% | +3.2% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | 12 | 0 |
| Dividend / ShareAnnual DPS | $0.21 | $1.51 | $1.43 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | 0.0% | +0.4% | +3.4% |
NBTB leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). NKSH leads in 1 (Profitability & Efficiency). 2 tied.
BRBS vs NKSH vs NBTB vs CARE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRBS or NKSH or NBTB or CARE a better buy right now?
For growth investors, NBT Bancorp Inc.
(NBTB) is the stronger pick with 10. 4% revenue growth year-over-year, versus -13. 4% for Blue Ridge Bankshares, Inc. (BRBS). NBT Bancorp Inc. (NBTB) offers the better valuation at 13. 5x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate National Bankshares, Inc. (NKSH) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRBS or NKSH or NBTB or CARE?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 13. 5x versus Blue Ridge Bankshares, Inc. at 31. 8x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NBT Bancorp Inc. wins at 1. 53x versus National Bankshares, Inc. 's 145. 48x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BRBS or NKSH or NBTB or CARE?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to -67. 7% for Blue Ridge Bankshares, Inc. (BRBS). Over 10 years, the gap is even starker: CARE returned +112. 9% versus BRBS's -12. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRBS or NKSH or NBTB or CARE?
By beta (market sensitivity over 5 years), Blue Ridge Bankshares, Inc.
(BRBS) is the lower-risk stock at 0. 54β versus NBT Bancorp Inc. 's 0. 89β — meaning NBTB is approximately 64% more volatile than BRBS relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 55% for Blue Ridge Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BRBS or NKSH or NBTB or CARE?
By revenue growth (latest reported year), NBT Bancorp Inc.
(NBTB) is pulling ahead at 10. 4% versus -13. 4% for Blue Ridge Bankshares, Inc. (BRBS). On earnings-per-share growth, the picture is similar: Blue Ridge Bankshares, Inc. grew EPS 135. 5% year-over-year, compared to 12. 5% for NBT Bancorp Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRBS or NKSH or NBTB or CARE?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 7. 1% for Blue Ridge Bankshares, Inc. — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 9. 1% for BRBS. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRBS or NKSH or NBTB or CARE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NBT Bancorp Inc. (NBTB) is the more undervalued stock at a PEG of 1. 53x versus National Bankshares, Inc. 's 145. 48x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 11. 7x for National Bankshares, Inc. — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 1% to $27. 00.
08Which pays a better dividend — BRBS or NKSH or NBTB or CARE?
In this comparison, BRBS (6.
1% yield), NKSH (4. 0% yield), NBTB (3. 2% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is BRBS or NKSH or NBTB or CARE better for a retirement portfolio?
For long-horizon retirement investors, Blue Ridge Bankshares, Inc.
(BRBS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 54), 6. 1% yield). Both have compounded well over 10 years (BRBS: -12. 5%, CARE: +112. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRBS and NKSH and NBTB and CARE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BRBS is a small-cap income-oriented stock; NKSH is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock. BRBS, NKSH, NBTB pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.